Immunohistochemical expression of estrogen and progesterone receptors in human colorectal adenoma and carcinoma using specified automated cellular image analysis system: A clinicopathological study

Oman Medical Journal

Volumn 26, Issue 5, 2011, Pages 307-314

  Qasim, Ban Jumaa ^a   Ali, Hussam Hasson ^a   Hussein, Alaa Ghani ^a  

^a Al Nahrain University College of Medicine   (Iraq)

Author keywords

Colorectal adenoma; Colorectal carcinoma; Estrogen receptors; Progesterone receptors

Indexed keywords

EID: 84858316561     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2011.78     Document Type: Article

References (29)

1. Elledge RM, Fuqua SA. Estrogen and Progesterone Receptors. Available at: http://drugswell.com/wowo/blog1.php/2011/01/16/estrogen-andprogesterone-receptors. Accessed at March 2011.
2. Cleveland AG, Oikarinen SI, Bynoté KK, Marttinen M, Rafter JJ, Gustafsson JA, et al. Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice. Carcinogenesis 2009 Sep;30(9):1581-1590.
3. Cho NL, Javid SH, Carothers AM, Redston M, Bertagnolli MM. Estrogen receptors α and β are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res 2007 Mar;67(5):2366-2372.
4. Ekem TE, Bahadir B, Gun BD, Bektas S, Kertis G, Yurdakan G, et al. Colorectal carcinomas: Clinicopathologic investigation, correlation with expression of estrogen and progesterone receptors. Turkish Journal of Cancer 2008;38:118-122.
5. Jiang HP, Teng RY, Wang Q, Zhang X, Wang HH, Cao J, et al. Estrogen receptor alpha variant ERalpha46 mediates growth inhibition and apoptosis of human HT-29 colon adenocarcinoma cells in the presence of 17betaoestradiol. Chin Med J (Engl) 2008 Jun;121(11):1025-1031.
6. Grodstein F, Martinez ME, Platz EA, Giovannucci E, Colditz GA, Kautzky M, et al. Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 1998 May;128(9):705-712.
7. Schindler AE. Long-term use of progestogens: colon adenoma and colon carcinoma. Gynecol Endocrinol 2007 Oct;23(Suppl 1):42-44.
8. Zavarhei MD, Bidgoli SA, Ziyarani MM, Shariatpanahi M, Ardalan FA. Progesterone receptor positive colorectal tumors have lower thymidine phosphorylase expression: an immunohistochemical study. Pak J Biol Sci 2007 Dec;10(24):4485-4489.
9. Qasim ZJ. Co-expression of (VEGF A, VEGF C, COX2and EGFR) biomarkers in human colorectal cancer and their association with lymph node metastasis and angiogenesis. A Thesis Submitted to College of Medicine -Al-Nahrain University2010.
10. Bing Z, Chuanmin Z. Progress of relationship between ER, PR and prognosis of colorectal cancer. Medical Recapitulate 2008;21:14-20.
11. Koo JH, Leong RW. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol 2010 Jan;25(1):33-42.
12. Meggouh F, Lointier P, Pezet D, Saez S. Status of sex steroid hormone receptors in large bowel cancer. Cancer 1991 Apr;67(7):1964-1970.
13. Di Leo A, Messa C, Russo F, Misciagna G, Guerra V, Taveri R, et al. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results. Dig Dis Sci 1994 Sep;39(9):2038-2042.
14. Slattery ML, Samowitz WS, Holden JA. Estrogen and progesterone receptors in colon tumors. Am J Clin Pathol 2000 Mar;113(3):364-368.
15. Cameron BL, Butler JA, Rutgers J, Vargas HI, Purtell M, Sheppard B. Immunohistochemical determination of the estrogen receptor content of gastrointestinal adenocarcinomas. Am Surg 1992 Dec;58(12):758-760.
16. Kaklamanos IG, Bathe OF, Franceschi D, Lazaris AC, Davaris P, Glinatsis M, et al. Expression of receptors for estrogen and progesterone in malignant colonic mucosa as a prognostic factor for patient survival. J Surg Oncol 1999 Dec;72(4):225-229.
17. Wenxi W, Lizong S, Dongming Y, et al. Expression of estrogen receptor and P glycoprotein in primary colorectal carcinoma. The Practical Journal of Cancer 1999;03:20-28.
18. Jun-Yan L. Receptors of estrogen and progesterone in human colorectal carcinoma: detection and their significance in the prognosis. Practical Clinical Medicine 2002;03:16-20.
19. Zike Q, Desen W, Junyan L, et al. Expression of nm23 protein and estrogen receptor and prognosis of colorectal cancers. Chinese Journal of Surgery 2000;07:12-16.
20. Zike Q, Desen W, Jun-yan L, Han-liang L, Jing-hui H. Expression and prognostic values of p21 protein and estrogen receptor in colorectal cancers. Chinese Journal of Cancer 2001;20:5-9.
21. Zhou ZW, Wan DS, Wang GQ, Pan ZZ, Lu HP, Gao JH, et al. Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study. Ai Zheng 2004 Jul;23(7):851-854.
22. Meggouh F, Lointier P, Saez S. Sex steroid and 1,25-dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Res 1991 Feb;51(4):1227-1233.
23. Qi L, Sonen Z, Shifeng Z. The detection of ER, PR and DNA ploidy,p53 gene in colorectal cancer and its clinical value. Journal of Chongqing Medical University 2009;08:32-37.
24. Marugo M, Molinari F, Fazzuoli L, Parodi MC, Bernasconi D, Menozzi F, et al. Estradiol and progesterone receptors in normal and pathologic colonic mucosa in humans. J Endocrinol Invest 1985 Apr;8(2):117-119.
25. Concolino G, Arrabito G, Buonomo O, Paesani P, Conti C, Picardi C. Nuclear steroid receptors and dysplasia in adenomatous polyps of the colon as markers of high risk for malignant transformation. Cancer Detect Prev 1986;9(5-6):477-484.
26. Uehara Y, Kojima O, Takemoto Y, Majima T, Takahashi T, Tada M. Immunohistochemical study of endogenous estrogen in colorectal cancer and adenomatous polyp tissue. Dig Surg 1986; 3:236-239.
27. Galandiuk S, Miseljic S, Yang AR, Early M, McCoy MD, Wittliff JL. Expression of hormone receptors, cathepsin D, and HER-2/neu oncoprotein in normal colon and colonic disease. Arch Surg 1993 Jun;128(6):637-642.
28. Hendrickse CW, Jones CE, Donovan IA, Neoptolemos JP, Baker PR. Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines. Br J Surg 1993 May;80(5):636-640.
29. Wang S, Saboorian MH, Frenkel EP, Haley BB, Siddiqui MT, Gokaslan S, et al. Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. Am J Clin Pathol 2001 Oct;116(4):495-503.